Acral cutaneous malignant melanoma treated with linear accelerator-based boron neutron capture therapy system: a case report of first patient.

Igaki, Hiroshi; Nakamura, Satoshi; Yamazaki, Naoya; Kaneda, Tomoya; Takemori, Mihiro; Kashihara, Tairo; Murakami, Naoya; Namikawa, Kenjiro; Nakaichi, Tetsu; Okamoto, Hiroyuki; Iijima, Kotaro; Chiba, Takahito; Nakayama, Hiroki; Nagao, Ayaka; Sakuramachi, Madoka; Takahashi, Kana; Inaba, Koji; Okuma, Kae; Nakayama, Yuko; Shimada, Kazuaki; Nakagama, Hitoshi; Itami, Jun

Igaki, Hiroshi; Nakamura, Satoshi; Yamazaki, Naoya; Kaneda, Tomoya; Takemori, Mihiro; Kashihara, Tairo; Murakami, Naoya; Namikawa, Kenjiro; Nakaichi, Tetsu; Okamoto, Hiroyuki; Iijima, Kotaro; Chiba, Takahito; Nakayama, Hiroki; Nagao, Ayaka; Sakuramachi, Madoka; Takahashi, Kana; Inaba, Koji; Okuma, Kae; Nakayama, Yuko; Shimada, Kazuaki; Nakagama, Hitoshi; Itami, Jun.

Afiliação

Igaki H; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Nakamura S; Division of Research and Development for Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, Tokyo, Japan.
Yamazaki N; Division of Research and Development for Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, Tokyo, Japan.
Kaneda T; Division of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan.
Takemori M; Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Kashihara T; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Murakami N; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Namikawa K; Division of Research and Development for Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, Tokyo, Japan.
Nakaichi T; Division of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan.
Okamoto H; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Iijima K; Division of Research and Development for Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, Tokyo, Japan.
Chiba T; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Nakayama H; Department of Radiation Oncology, Jutendo University School of Medicine, Tokyo, Japan.
Nagao A; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Sakuramachi M; Division of Research and Development for Boron Neutron Capture Therapy, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, Tokyo, Japan.
Takahashi K; Division of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan.
Inaba K; Division of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan.
Okuma K; Department of Radiation Oncology, Jutendo University School of Medicine, Tokyo, Japan.
Nakayama Y; Division of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan.
Shimada K; Department of Radiological Science, Graduate School of Human Health Sciences, Tokyo Metropolitan University, Tokyo, Japan.
Nakagama H; Division of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan.
Itami J; Department of Radiological Science, Graduate School of Human Health Sciences, Tokyo Metropolitan University, Tokyo, Japan.

Front Oncol ; 13: 1272507, 2023.

Article em En | MEDLINE | ID: mdl-37901311

Palavras-chave

acral malignant melanoma; boron neutron capture therapy (BNCT); first treatment; linear accelerator-based BNCT system; malignant melanoma; solid-state Li target

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão